Papers › Sensitivity Analysis for the Test-Negative Design
Sensitivity Analysis for the Test-Negative Design
Soumyabrata Kundu, Peng Ding, Jingshu Wang, Xinran Li
The archive published only this paper's code-link row. Authors, date and abstract are from arXiv's metadata (CC0), read from the Kaggle arXiv metadata snapshot of 2026-09-12 where its title matched the archive's; the title is the archive's.
The test-negative design has become popular for evaluating the effectiveness of post-licensure vaccines using observational data. In addition to its logistical convenience on data collection, the design is also believed to control for the differential health-care-seeking behavior between vaccinated and unvaccinated individuals, an important while often unmeasured confounder between the vaccination and infection. Hence, the design has been employed routinely to monitor seasonal flu vaccines and more recently to measure the COVID-19 vaccine effectiveness. Despite its popularity, the design has been questioned, in particular about its ability to fully control for the unmeasured confounding. In this paper, we explore deviations from a perfect test-negative design, and propose various sensitivity analysis methods for estimating the effect of vaccination measured by the causal odds ratio on the subpopulation of individuals with good health-care-seeking behavior. We start with point identification of the causal odds ratio under a test-negative design, comparing different forms of identification assumptions and their corresponding estimands. We then propose two approaches for conducting sensitivity analysis, addressing the influence of the unmeasured confounding in two different ways. Specifically, one approach investigates partial control for unmeasured confounding in the test-negative design, while the other examines the impact of unmeasured confounding on both vaccination and infection. Furthermore, we combine these approaches to provide narrower bounds on the true causal odds ratio, and further sharpen the bounds by restricting the treatment effect heterogeneity. Finally, we apply the proposed methods to evaluate the effectiveness of COVID-19 vaccines using observational data from test-negative designs.
Code
Repository list and official/mentioned flags are the archive's, frozen 2025-07-28. Reachability, where shown, is from one Syntology probe window (2026-09-16 to 2026-09-18); repositories not probed show nothing. GitHub stars are not tracked.
Code Syntology ran Syntology
Not run by Syntology. Nothing on this page verifies that the listed code works.
Results from the paper archive 2025-07-28
No leaderboard rows for this paper in the archive.
Report a problem or propose a change · a person checks every report against the paper or source before anything changes; decisions are listed on /corrections